(Press-News.org) LOS ANGELES (Aug. 9, 2013) – A unique nanoscale drug that can carry a variety of weapons and sneak into cancer cells to break them down from the inside has a new component: a protein that stimulates the immune system to attack HER2-positive breast cancer cells.
The research team developing the drug – led by scientists at the Nanomedicine Research Center, part of the Maxine Dunitz Neurosurgical Institute in the Department of Neurosurgery at Cedars-Sinai Medical Center – conducted the study in laboratory mice with implanted human breast cancer cells. Mice receiving the drug lived significantly longer than untreated counterparts and those receiving only certain components of the drug, according to a recent article in the Journal of Controlled Release.
Researchers from the Samuel Oschin Comprehensive Cancer Institute at Cedars-Sinai, the Division of Surgical Oncology at UCLA, and the Molecular Biology Institute at UCLA also participated in the study.
Unlike other drugs that target cancer cells from the outside, often injuring normal cells as a side effect, this therapy consists of multiple drugs chemically bonded to a "nanoplatform" that functions as a transport vehicle.
HER2-positive cancers – making up 25 to 30 percent of breast and ovarian cancers – tend to be more aggressive and less responsive to treatment than others because the overactive HER2 gene makes excessive amounts of a protein that promotes cancer growth. One commonly used drug, Herceptin (trastuzumab), often is effective for a while, but many tumors become resistant within the first year of treatment and the drug can injure normal organs it contacts.
But Herceptin is an antibody to the HER2 gene – it naturally seeks out this protein – so the research team used key parts of Herceptin to guide the nanodrug into HER2-positive cancer cells.
"We genetically prepared a new 'fusion gene' that consists of an immune-stimulating protein, interleukin-2, and a gene of Herceptin," said Julia Y. Ljubimova, MD, PhD, professor of neurosurgery and biomedical sciences and director of the Nanomedicine Research Center. "IL-2 activates a variety of immune cells but is not stable in blood plasma and does not home specifically to tumor cells. By attaching the new fusion antibody to the nanoplatform, we were able to deliver Herceptin directly to HER2-positive cancer cells, at the same time transporting IL-2 to the tumor site to stimulate the immune system. Attaching IL-2 to the platform helped stabilize the protein and allowed us to double the dosage that could be delivered to the tumor."
Ljubimova led the study with Manuel Penichet, MD, PhD, associate professor of surgery, microbiology, immunology and molecular genetics at the University of California, Los Angeles, David Geffen School of Medicine. Ljubimova said the UCLA collaborators developed the fusion gene, and Cedars-Sinai chemists Eggehard Holler, PhD, professor in the Department of Neurosurgery, and Hui Ding, PhD, assistant professor, performed the technically difficult task of attaching it to the nanoplatform. Ding is the journal article's first author.
The researchers also attached other components, such as molecules to block a protein (laminin-411) that cancer cells need to make new blood vessels for growth.
The nanodrug, Polycefin, is in an emerging class called nanobiopolymeric conjugates, nanoconjugates or nanobioconjugates. They are the latest evolution of molecular drugs designed to slow or stop cancers by blocking them in multiple ways. Polycefin is intended to slow their growth by entering cells and altering defined targets. The new version also stimulates the immune system to further weaken cancers.
"We believe this is the first time a drug has been designed for nano-immunology anti-cancer treatment," Ljubimova said.
Bioconjugates are drugs that contain chemical "modules" attached (conjugated) to a delivery vehicle by strong chemical bonds. The nanoconjugate exists as a single chemical unit, and the tight bonds prevent the components from getting damaged or separated in tissues or blood plasma during transit. With inventive drug engineering, the anti-tumor components activate inside tumor cells.
"More study is needed to confirm our findings, improve the effectiveness of this approach and shed light on the anti-cancer mechanisms at work, but it appears that the nanobioconjugate may represent a new generation of cancer therapeutics in which we launch a multipronged attack that directly kills cancer cells, blocks the growth of cancer-supporting blood vessels and stimulates a powerful antitumor immune response," Ljubimova said, adding that this and previous animal studies have found the nanodrug to be a safe and efficient delivery platform.
Nano researchers manipulate substances and materials at the atomic level, generally working with substances smaller than 100 nanometers. Cedars-Sinai's nanoconjugate is estimated to be about 27 nanometers wide. A human hair is 80,000 to 100,000 nanometers wide.
###
This study was supported in part by grants from the National Institutes of Health/National Cancer Institute (R01CA123459, U01CA151815, R01CA136841, K01CA138559. Additional support came from the UC MEXUS-CONACYT Fellowship Program, the Howard Hughes Medical Institute Gilliam Fellowship, the Whitcome Fellowship of the Molecular Biology Institute at UCLA, ANPCyT-FONARSEC PICT-PRH 2008-00315, the CONICET PIP no. 114-2011-01-00139, and the UBACYT No 200-2011-02-00027. The UCLA Flow Cytometry Core Facility is supported by NIH awards CA16042 and AI28697, the Jonsson Cancer Center, the UCLA AIDS Institute and the UCLA School of Medicine.
Citation: Journal of Controlled Release, "Polymalic acid nanobioconjugate for simultaneous immunostimulation and inhibition of tumor growth in HER2/neu-positive breast cancer"
END
Contact: Marco Leyton, Ph.D.
marco.leyton@mcgill.ca
514-398-5804
McGill University
Terry E. Robinson, Ph.D.
ter@umich.edu
734-358-8055
The University of Michigan
Alcoholism: Clinical & Experimental Research
Brain dopamine may serve as a risk marker for alcohol use disorders
There are known risks for and protective factors against the development of alcohol use disorders (AUDs).
A new study has found that striatal dopamine responses to alcohol ingestion may serve as a neurobiological marker of vulnerability to AUDs.
Specifically, when given alcohol, ...
Research from McGill University suggests that people who are vulnerable to developing alcoholism exhibit a distinctive brain response when drinking alcohol, according to a new study by Prof. Marco Leyton, of McGill University's Department of Psychiatry. Compared to people at low risk for alcohol-use problems, those at high risk showed a greater dopamine response in a brain pathway that increases desire for rewards. These findings, published in the journal Alcoholism: Clinical & Experimental Research, could help shed light on why some people are more at risk of suffering ...
The Black Forest wildfire this June was one of the most destructive in Colorado history, in terms of homes lost. It started close to houses and quickly spread through the ponderosa pine canopies on the rolling hills near Colorado Springs. The wildfire destroyed 500 homes in the first 48 hours and killed two people.
Hot, dry and windy weather played a role in that wildfire, said Don Smurthwaite, spokesperson with the National Interagency Fire Center (NIFC) in Boise, Idaho.
"Fire seasons are getting longer, western regions are getting drier, and more people are living ...
NEW YORK CITY -- Children who overestimate their popularity are less likely to be bullies than those who underestimate or hold more accurate assessments of their social standing, finds new research to be presented at the 108th Annual Meeting of the American Sociological Association.
"The more kids overestimated their popularity, the less aggression they displayed," said Jennifer Watling Neal, an assistant professor of psychology at Michigan State University. "This means that kids who were more accurate in their assessment of their number of friends or who underestimated ...
NEW YORK CITY -- People have more empathy for battered puppies and full grown dogs than they do for some humans -- adults, but not children, finds new research to be presented at the 108th Annual Meeting of the American Sociological Association.
"Contrary to popular thinking, we are not necessarily more disturbed by animal rather than human suffering," said Jack Levin, the Irving and Betty Brudnick Professor of Sociology and Criminology at Northeastern University. "Our results indicate a much more complex situation with respect to the age and species of victims, with ...
NEW YORK CITY — Morning sickness, shiny hair, and bizarre and intense cravings for pickles and ice cream — what expectations do pregnant women impose on their bodies, and how are those expectations influenced by cultural perspectives on pregnancy?
Danielle Bessett, an assistant professor of sociology at the University of Cincinnati, will present her research on this issue at the 108th Annual Meeting of the American Sociological Association.
Although previous studies have indicated that women primarily rely on their health care providers and pregnancy guides to find ...
NEW YORK CITY — Immigration judges should be allowed to consider a person's family and social ties to the United States before ordering the deportation of legal permanent residents for minor offenses, says a professor at the University of California, Merced.
"The reason legal permanent residents can be deported for minor crimes — even if they have lived in the United States for many years — is that there is little to no due process in immigration courts," sociology Professor Tanya Golash-Boza said. "Under current laws, if a person has a prior conviction for a wide range ...
NEW YORK -- An Indiana University study found that college students' experiences are largely shaped by the debt they accrue, with debt-free students more likely to live the "play hard" lifestyle often associated with the college years, where social lives can trump academics.
Sociologist Daniel Rudel said this is one of the first studies to examine how student loan debt affects students' college experiences. He and colleague Natasha Yurk, also a graduate student in the Department of Sociology in IU Bloomington's College of Arts and Sciences, found "real and significant ...
In what is the biggest study of its kind to date, researchers from Technische Universität München (TUM) have identified over 10,000 different proteins in cancer cells. "Nearly all anti-tumor drugs are targeted against cellular proteins," says Prof. Bernhard Küster, Head of the TUM Chair of Proteomics and Bioanalytics. "Identifying the proteome the protein portfolio of tumor cells increases our chances of finding new targets for drugs."
The scientists investigated 59 tumor cell lines from the US National Cancer Institute. The "NCI-60" cell lines represent the most common ...
The California Health Interview Survey (CHIS) today released new data based on interviews with more than 44,000 households in California. The survey, conducted by the UCLA Center for Health Policy Research, covered hundreds of topics affecting state residents' health and well-being.
Data on nearly 200 of these topics were released today on AskCHIS, the center's award-winning, free, easy-to-use Web tool that provides data by state, region, county and some service-planning areas in Los Angeles and San Diego counties. Even more data were released through free, downloadable ...
